APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculin

Tuberculin, also known as purified protein derivative is a combination of proteins that are used in the diagnosis of tuberculosis. This use is referred to as the tuberculin skin test and is recommended only for those at high risk. Injection is done into the skin. After 48 to 72 hours if there is more than a five to ten millimeter area of swelling the test is considered positive.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Tuberculin, also known as purified protein derivative is a combination of proteins that are used in the diagnosis of tuberculosis. This use is referred to as the tuberculin skin test and is recommended only for those at high risk. Injection is done into the skin. After 48 to 72 hours if there is more than a five to ten millimeter area of swelling the test is considered positive.

A tuberculin skin test (also called a Mantoux tuberculin test) is done to see if people have ever been exposed to tuberculosis (TB). The test is done by putting a small amount of TB protein (antigens) under the top layer of skin on the inner forearm.

Selected research

Market Outlook & Growth Opportunities

Global Tuberculin Market Outlook and Growth Opportunities 2026

26 December 2025194 pages

Choose your research edition.

Industry ResearchTuberculin Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculin Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Tuberculin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculin Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Tuberculin, also known as purified protein derivative is a combination of proteins that are used in the diagnosis of tuberculosis. This use is referred to as the tuberculin skin test and is recommended only for those at high risk. Injection is done into the skin. After 48 to 72 hours if there is more than a five to ten millimeter area of swelling the test is considered positive.

A tuberculin skin test (also called a Mantoux tuberculin test) is done to see if people have ever been exposed to tuberculosis (TB). The test is done by putting a small amount of TB protein (antigens) under the top layer of skin on the inner forearm.

Global Tuberculin key players include Sanofi Pasteur, Zoetis, Par Sterile, SSI, etc. Global top four manufacturers hold a share about 75%.

Read the full market overview

North America is the largest market, with a share over 50%, followed by Japan and Europe, both have a share over 35 percent.

In terms of product, PPD-S is the largest segment, with a share about 50%. And in terms of application, the largest application is Human Use, followed by Animal Use.

This report provides an overview of the global Tuberculin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tuberculin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tuberculin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tuberculin market size, projected growth trends, production technologies, key applications, and end-use industries.

Tuberculin Segment by Company

Sanofi Pasteur

Zoetis

Par Sterile

SSI

Japan BCG

Thermo Fisher

Sanroad Biological

CNBG

Tuberculin Segment by Type

PPD-S

PPD RT23

Others

Tuberculin Segment by Application

Human Use

Animal Use

Tuberculin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tuberculin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tuberculin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tuberculin significant trends, drivers, influence factors in global and regions.

6. To analyze Tuberculin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tuberculin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tuberculin industry.

Chapter 3: Detailed analysis of Tuberculin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tuberculin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tuberculin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tuberculin Industry Trends Table 2. Tuberculin Industry Drivers Table 3. Tuberculin Industry Opportunities and Challenges Table 4. Tuberculin Industry Restraints Table 5. Global Tuberculin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tuberculin Revenue Share by Company (2021-2026) Table 7. Global Tuberculin Sales Volume by Company (K Vial) & (2021-2026) Table 8. Global Tuberculin Sales Volume Share by Company (2021-2026) Table 9. Global Tuberculin Average Price (USD/Vial) of Company (2021-2026) Table 10. Global Tuberculin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tuberculin Key Company Manufacturing Base & Headquarters Table 12. Global Tuberculin Company, Product Type & Application Table 13. Global Tuberculin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tuberculin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PPD-S Table 18. Significant Companies of PPD RT23 Table 19. Significant Companies of Others Table 20. Global Tuberculin Sales Volume by Type 2021 VS 2025 VS 2032 (K Vial) Table 21. Global Tuberculin Sales Volume by Type (2021-2026) & (K Vial) Table 22. Global Tuberculin Sales Volume by Type (2027-2032) & (K Vial) Table 23. Global Tuberculin Sales Volume Share by Type (2021-2026) Table 24. Global Tuberculin Sales Volume Share by Type (2027-2032) Table 25. Global Tuberculin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Tuberculin Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Tuberculin Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Tuberculin Sales Value Share by Type (2021-2026) Table 29. Global Tuberculin Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Human Use Table 31. Significant Companies of Animal Use Table 32. Global Tuberculin Sales Volume by Application 2021 VS 2025 VS 2032 (K Vial) Table 33. Global Tuberculin Sales Volume by Application (2021-2026) & (K Vial) Table 34. Global Tuberculin Sales Volume by Application (2027-2032) & (K Vial) Table 35. Global Tuberculin Sales Volume Share by Application (2021-2026) Table 36. Global Tuberculin Sales Volume Share by Application (2027-2032) Table 37. Global Tuberculin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Tuberculin Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Tuberculin Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Tuberculin Sales Value Share by Application (2021-2026) Table 41. Global Tuberculin Sales Value Share by Application (2027-2032) Table 42. Global Tuberculin Sales by Region: 2021 VS 2025 VS 2032 (K Vial) Table 43. Global Tuberculin Sales by Region (2021-2026) & (K Vial) Table 44. Global Tuberculin Sales Market Share by Region (2021-2026) Table 45. Global Tuberculin Sales by Region (2027-2032) & (K Vial) Table 46. Global Tuberculin Sales Market Share by Region (2027-2032) Table 47. Global Tuberculin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Tuberculin Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Tuberculin Sales Value Share by Region (2021-2026) Table 50. Global Tuberculin Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Tuberculin Sales Value Share by Region (2027-2032) Table 52. Global Tuberculin Market Average Price (USD/Vial) by Region (2021-2026) Table 53. Global Tuberculin Market Average Price (USD/Vial) by Region (2027-2032) Table 54. Global Tuberculin Sales by Country: 2021 VS 2025 VS 2032 (K Vial) Table 55. Global Tuberculin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Tuberculin Sales by Country (2021-2026) & (K Vial) Table 57. Global Tuberculin Sales Market Share by Country (2021-2026) Table 58. Global Tuberculin Sales by Country (2027-2032) & (K Vial) Table 59. Global Tuberculin Sales Market Share by Country (2027-2032) Table 60. Global Tuberculin Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Tuberculin Sales Value Market Share by Country (2021-2026) Table 62. Global Tuberculin Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Tuberculin Sales Value Market Share by Country (2027-2032) Table 64. Sanofi Pasteur Company Information Table 65. Sanofi Pasteur Business Overview Table 66. Sanofi Pasteur Tuberculin Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 67. Sanofi Pasteur Tuberculin Product Portfolio Table 68. Sanofi Pasteur Recent Development Table 69. Zoetis Company Information Table 70. Zoetis Business Overview Table 71. Zoetis Tuberculin Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 72. Zoetis Tuberculin Product Portfolio Table 73. Zoetis Recent Development Table 74. Par Sterile Company Information Table 75. Par Sterile Business Overview Table 76. Par Sterile Tuberculin Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 77. Par Sterile Tuberculin Product Portfolio Table 78. Par Sterile Recent Development Table 79. SSI Company Information Table 80. SSI Business Overview Table 81. SSI Tuberculin Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 82. SSI Tuberculin Product Portfolio Table 83. SSI Recent Development Table 84. Japan BCG Company Information Table 85. Japan BCG Business Overview Table 86. Japan BCG Tuberculin Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 87. Japan BCG Tuberculin Product Portfolio Table 88. Japan BCG Recent Development Table 89. Thermo Fisher Company Information Table 90. Thermo Fisher Business Overview Table 91. Thermo Fisher Tuberculin Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 92. Thermo Fisher Tuberculin Product Portfolio Table 93. Thermo Fisher Recent Development Table 94. Sanroad Biological Company Information Table 95. Sanroad Biological Business Overview Table 96. Sanroad Biological Tuberculin Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 97. Sanroad Biological Tuberculin Product Portfolio Table 98. Sanroad Biological Recent Development Table 99. CNBG Company Information Table 100. CNBG Business Overview Table 101. CNBG Tuberculin Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 102. CNBG Tuberculin Product Portfolio Table 103. CNBG Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Tuberculin Distributors List Table 107. Tuberculin Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Tuberculin Product Image Figure 2. Global Tuberculin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tuberculin Sales (2021-2032) & (K Vial) Figure 5. Global Tuberculin Sales Average Price (USD/Vial) & (2021-2032) Figure 6. Global Tuberculin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PPD-S Image Figure 10. PPD RT23 Image Figure 11. Others Image Figure 12. Global Tuberculin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Vial) Figure 13. Global Tuberculin Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Tuberculin Sales Volume Share by Type (2021-2032) Figure 15. Global Tuberculin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Tuberculin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Tuberculin Sales Value Share by Type (2021-2032) Figure 18. Human Use Image Figure 19. Animal Use Image Figure 20. Global Tuberculin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Vial) Figure 21. Global Tuberculin Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Tuberculin Sales Volume Share by Application (2021-2032) Figure 23. Global Tuberculin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Tuberculin Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Tuberculin Sales Value Share by Application (2021-2032) Figure 26. Global Tuberculin Sales by Region: 2021 VS 2025 VS 2032 (K Vial) Figure 27. Global Tuberculin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Tuberculin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Tuberculin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Tuberculin Sales Value (2021-2032) & (US$ Million) Figure 31. North America Tuberculin Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Tuberculin Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Tuberculin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Tuberculin Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Tuberculin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Tuberculin Sales Value (2021-2032) & (US$ Million) Figure 37. South America Tuberculin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Tuberculin Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Tuberculin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Tuberculin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Tuberculin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Tuberculin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Tuberculin Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Tuberculin Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • PPD-S
  • PPD RT23
  • Others
Applications
  • Human Use
  • Animal Use
Companies covered
  • Sanofi Pasteur
  • Zoetis
  • Par Sterile
  • SSI
  • Japan BCG
  • Thermo Fisher
  • Sanroad Biological
  • CNBG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tuberculin Sales Value (2021-2032)
  4. 1.2.2 Global Tuberculin Sales Volume (2021-2032)
  5. 1.2.3 Global Tuberculin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tuberculin Market Dynamics
  1. 2.1 Tuberculin Industry Trends
  2. 2.2 Tuberculin Industry Drivers
  3. 2.3 Tuberculin Industry Opportunities and Challenges
  4. 2.4 Tuberculin Industry Restraints
3 Tuberculin Market by Company
  1. 3.1 Global Tuberculin Company Revenue Ranking in 2025
  2. 3.2 Global Tuberculin Revenue by Company (2021-2026)
  3. 3.3 Global Tuberculin Sales Volume by Company (2021-2026)
  4. 3.4 Global Tuberculin Average Price by Company (2021-2026)
  5. 3.5 Global Tuberculin Company Ranking (2024-2026)
  6. 3.6 Global Tuberculin Company Manufacturing Base and Headquarters
  7. 3.7 Global Tuberculin Company Product Type and Application
  8. 3.8 Global Tuberculin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tuberculin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tuberculin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tuberculin Market by Type
  1. 4.1 Tuberculin Type Introduction
  2. 4.1.1 PPD-S
  3. 4.1.2 PPD RT23
  4. 4.1.3 Others
  5. 4.2 Global Tuberculin Sales Volume by Type
  6. 4.2.1 Global Tuberculin Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Tuberculin Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Tuberculin Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Tuberculin Sales Value by Type
  10. 4.3.1 Global Tuberculin Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Tuberculin Sales Value by Type (2021-2032)
  12. 4.3.3 Global Tuberculin Sales Value Share by Type (2021-2032)
5 Tuberculin Market by Application
  1. 5.1 Tuberculin Application Introduction
  2. 5.1.1 Human Use
  3. 5.1.2 Animal Use
  4. 5.2 Global Tuberculin Sales Volume by Application
  5. 5.2.1 Global Tuberculin Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Tuberculin Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Tuberculin Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Tuberculin Sales Value by Application
  9. 5.3.1 Global Tuberculin Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Tuberculin Sales Value by Application (2021-2032)
  11. 5.3.3 Global Tuberculin Sales Value Share by Application (2021-2032)
6 Tuberculin Regional Sales and Value Analysis
  1. 6.1 Global Tuberculin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tuberculin Sales by Region (2021-2032)
  3. 6.2.1 Global Tuberculin Sales by Region: 2021-2026
  4. 6.2.2 Global Tuberculin Sales by Region (2027-2032)
  5. 6.3 Global Tuberculin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tuberculin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tuberculin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tuberculin Sales Value by Region (2027-2032)
  9. 6.5 Global Tuberculin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tuberculin Sales Value (2021-2032)
  12. 6.6.2 North America Tuberculin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tuberculin Sales Value (2021-2032)
  15. 6.7.2 Europe Tuberculin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tuberculin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tuberculin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tuberculin Sales Value (2021-2032)
  21. 6.9.2 South America Tuberculin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tuberculin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tuberculin Sales Value Share by Country, 2025 VS 2032
7 Tuberculin Country-level Sales and Value Analysis
  1. 7.1 Global Tuberculin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tuberculin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tuberculin Sales by Country (2021-2032)
  4. 7.3.1 Global Tuberculin Sales by Country (2021-2026)
  5. 7.3.2 Global Tuberculin Sales by Country (2027-2032)
  6. 7.4 Global Tuberculin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tuberculin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tuberculin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tuberculin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tuberculin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tuberculin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tuberculin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tuberculin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tuberculin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tuberculin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tuberculin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tuberculin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tuberculin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tuberculin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tuberculin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tuberculin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tuberculin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tuberculin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tuberculin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tuberculin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tuberculin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tuberculin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tuberculin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tuberculin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tuberculin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tuberculin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tuberculin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tuberculin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tuberculin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tuberculin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tuberculin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tuberculin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tuberculin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tuberculin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tuberculin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tuberculin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tuberculin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tuberculin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tuberculin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tuberculin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tuberculin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tuberculin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tuberculin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tuberculin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tuberculin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tuberculin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tuberculin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tuberculin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tuberculin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tuberculin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tuberculin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tuberculin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tuberculin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tuberculin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tuberculin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tuberculin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tuberculin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tuberculin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tuberculin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tuberculin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tuberculin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tuberculin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tuberculin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tuberculin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tuberculin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tuberculin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tuberculin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tuberculin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tuberculin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tuberculin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tuberculin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tuberculin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tuberculin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tuberculin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tuberculin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tuberculin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tuberculin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tuberculin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tuberculin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tuberculin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tuberculin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tuberculin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tuberculin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tuberculin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tuberculin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tuberculin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tuberculin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi Pasteur
  2. 8.1.1 Sanofi Pasteur Company Information
  3. 8.1.2 Sanofi Pasteur Business Overview
  4. 8.1.3 Sanofi Pasteur Tuberculin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pasteur Tuberculin Product Portfolio
  6. 8.1.5 Sanofi Pasteur Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Tuberculin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Tuberculin Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Par Sterile
  14. 8.3.1 Par Sterile Company Information
  15. 8.3.2 Par Sterile Business Overview
  16. 8.3.3 Par Sterile Tuberculin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Par Sterile Tuberculin Product Portfolio
  18. 8.3.5 Par Sterile Recent Developments
  19. 8.4 SSI
  20. 8.4.1 SSI Company Information
  21. 8.4.2 SSI Business Overview
  22. 8.4.3 SSI Tuberculin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 SSI Tuberculin Product Portfolio
  24. 8.4.5 SSI Recent Developments
  25. 8.5 Japan BCG
  26. 8.5.1 Japan BCG Company Information
  27. 8.5.2 Japan BCG Business Overview
  28. 8.5.3 Japan BCG Tuberculin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Japan BCG Tuberculin Product Portfolio
  30. 8.5.5 Japan BCG Recent Developments
  31. 8.6 Thermo Fisher
  32. 8.6.1 Thermo Fisher Company Information
  33. 8.6.2 Thermo Fisher Business Overview
  34. 8.6.3 Thermo Fisher Tuberculin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Thermo Fisher Tuberculin Product Portfolio
  36. 8.6.5 Thermo Fisher Recent Developments
  37. 8.7 Sanroad Biological
  38. 8.7.1 Sanroad Biological Company Information
  39. 8.7.2 Sanroad Biological Business Overview
  40. 8.7.3 Sanroad Biological Tuberculin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sanroad Biological Tuberculin Product Portfolio
  42. 8.7.5 Sanroad Biological Recent Developments
  43. 8.8 CNBG
  44. 8.8.1 CNBG Company Information
  45. 8.8.2 CNBG Business Overview
  46. 8.8.3 CNBG Tuberculin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CNBG Tuberculin Product Portfolio
  48. 8.8.5 CNBG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tuberculin Value Chain Analysis
  2. 9.1.1 Tuberculin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tuberculin Sales Mode & Process
  6. 9.2 Tuberculin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tuberculin Distributors
  9. 9.2.3 Tuberculin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst